Growth Metrics

Vertex Pharmaceuticals (VRTX) EBT (QoQ) (2009 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Revolution Medicines 32.39 Bn 32.39 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -5.87%
Dec 31, 2025 2.48%
Sep 30, 2025 1.23%
Jun 30, 2025 75.66%
Mar 31, 2025 -35.73%
Dec 31, 2024 -7.16%
Sep 30, 2024 136.10%
Jun 30, 2024 -365.12%
Mar 31, 2024 11.46%
Dec 31, 2023 -2.68%
Sep 30, 2023 1.52%
Jun 30, 2023 30.29%
Mar 31, 2023 -17.21%
Dec 31, 2022 -8.47%
Sep 30, 2022 14.84%
Jun 30, 2022 7.29%
Mar 31, 2022 9.63%
Dec 31, 2021 -19.57%
Sep 30, 2021 2,549.77%
Jun 30, 2021 -105.38%
Mar 31, 2021 -7.62%
Dec 31, 2020 19.14%
Sep 30, 2020 -9.57%
Jun 30, 2020 25.43%
Mar 31, 2020 -2.87%
Dec 31, 2019 857.96%
Sep 30, 2019 -78.40%
Jun 30, 2019 2.18%
Mar 31, 2019 885.21%
Dec 31, 2018 -76.19%
Sep 30, 2018 -36.97%
Jun 30, 2018 0.91%
Mar 31, 2018 90.89%
Dec 31, 2017 126.95%
Sep 30, 2017 -1,274.93%
Jun 30, 2017 -86.00%
Mar 31, 2017 1,148.56%
Dec 31, 2016 152.02%
Sep 30, 2016 -116.60%
Jun 30, 2016 41.14%
Mar 31, 2016 59.74%
Dec 31, 2015 17.77%
Sep 30, 2015 51.54%
Jun 30, 2015 3.80%
Mar 31, 2015 -11.09%
Dec 31, 2014 -7.21%
Sep 30, 2014 -5.16%
Jun 30, 2014 31.52%
Mar 31, 2014 -1,082.07%
Dec 31, 2013 83.54%
Sep 30, 2013 -121.03%
Jun 30, 2013 87.60%
Mar 31, 2013 -437.05%
Dec 31, 2012 -1,480.05%
Sep 30, 2012 64.51%
Jun 30, 2012 -116.39%
Mar 31, 2012 -58.30%
Dec 31, 2011 5.08%
Mar 31, 2011 2.38%
Dec 31, 2010 13.67%
Sep 30, 2010 -4.48%
Jun 30, 2010 -22.12%
Mar 31, 2010 -8.50%
Dec 31, 2009 -0.93%
Sep 30, 2009 5.94%
Jun 30, 2009 2.26%